These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7889692)

  • 1. Different types of plasminogen activator activity in human brain tumours: relation with peritumoral oedema?
    Gijtenbeek JM; Emeis JJ; van der Sande JJ; Lulf RE
    Clin Neurol Neurosurg; 1994 Nov; 96(4):305-9. PubMed ID: 7889692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histochemical study of alkaline phosphatase in primary human brain tumors: diagnostic implications for meningiomas and neurinomas.
    Murakami M; Kuratsu J; Mihara Y; Matsuno K; Ushio Y
    Neurosurgery; 1993 Feb; 32(2):180-4; discussion 184. PubMed ID: 8382347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative venous thromboembolism and brain tumors: Part III. Biochemical profile.
    Sawaya R; Highsmith RF
    J Neurooncol; 1992 Oct; 14(2):113-8. PubMed ID: 1331347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
    Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
    Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours.
    Arai Y; Kubota T; Nakagawa T; Kabuto M; Sato K; Kobayashi H
    Acta Neurochir (Wien); 1998; 140(4):377-85; discussion 385-6. PubMed ID: 9689330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor prostaglandin levels correlate with edema around supratentorial meningiomas.
    Constantini S; Tamir J; Gomori MJ; Shohami E
    Neurosurgery; 1993 Aug; 33(2):204-10; discussion 211. PubMed ID: 8367041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin distribution in human brain tumours.
    Castellani P; Dorcaratto A; Siri A; Zardi L; Viale GL
    Acta Neurochir (Wien); 1995; 136(1-2):44-50. PubMed ID: 8748826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer.
    Casslén B; Bossmar T; Lecander I; Astedt B
    Eur J Cancer; 1994; 30A(9):1302-9. PubMed ID: 7999418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The study of plasminogen activator in renal cell carcinoma with special remarks on urokinase type plasminogen activator].
    Hata M
    Nihon Hinyokika Gakkai Zasshi; 1989 Nov; 80(11):1558-65. PubMed ID: 2512407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.
    de Bruin PA; Verspaget HW; Griffioen G; Verheijen JH; Dooijewaard G; Lamers CB
    Br J Cancer; 1989 Sep; 60(3):397-400. PubMed ID: 2506920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors involved in the plasminogen activation system in human breast tumours.
    Damjanovich L; Turzó C; Adány R
    Thromb Haemost; 1994 Jun; 71(6):684-91. PubMed ID: 7974332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator activity and molecular weight patterns in human brain tumors.
    Sawaya R; Highsmith R
    J Neurosurg; 1988 Jan; 68(1):73-9. PubMed ID: 3335914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
    De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN
    J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
    Ganesh S; Sier CF; Heerding MM; van Krieken JH; Griffioen G; Welvaart K; van de Velde CJ; Verheijen JH; Lamers CB; Verspaget HW
    Br J Cancer; 1997; 75(12):1793-801. PubMed ID: 9192984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the interaction effects Ar+ laser-brain tumours by study of the photoacoustic spectroscopy of cerebral oncotypes.
    De Tommasi A; Occhiogrosso M; Vailati G; Baldassarre L; Cingolani A
    Acta Neurochir (Wien); 1990; 104(1-2):27-9. PubMed ID: 2166995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators in human gastric cancers: correlation with DNA ploidy and immunohistochemical staining.
    Takai S; Yamamura M; Tanaka K; Kawanishi H; Tsuji M; Nakane Y; Hioki K; Yamamoto M
    Int J Cancer; 1991 Apr; 48(1):20-7. PubMed ID: 1902201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of peritumoral brain edema following excision of meningioma.
    Shirotani T; Shima K; Chigasaki H
    Acta Neurochir Suppl (Wien); 1994; 60():416-8. PubMed ID: 7976606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells.
    Koretz K; Möller P; Schwartz-Albiez R
    Eur J Cancer; 1993; 29A(8):1184-9. PubMed ID: 8518031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericytosis and edema generation: a unique clinicopathological variant of meningioma.
    Robinson JC; Challa VR; Jones DS; Kelly DL
    Neurosurgery; 1996 Oct; 39(4):700-6; discussion 706-7. PubMed ID: 8880761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple forms of plasminogen activator in human breast tumors.
    O'Grady P; Lijnen HR; Duffy MJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6216-8. PubMed ID: 3933824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.